Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products.

Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.

Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF)(FSE: LB6A.F) is a featured sponsored company and has paid SmallCapPower.com a fee for coverage. To learn more, see our full disclosure HERE >>

FINANCIAL ANALYSIS

CONTACT

>
Isodiol International Inc. (CSE: ISOL) 2710 - 200 Granville Street, Vancouver, British Columbia, V6C 1S4 Company Website

RECEIVE COMPANY UPDATES



PRESS RELEASE